Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers-Reference-Cited by-同舟云学术

Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers

Published:2017-04-01 Issue:4 Volume:3 Page:472
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Sinicrope Frank A.¹,Shi Qian²,Allegra Carmen J.³,Smyrk Thomas C.⁴,Thibodeau Stephen N.⁴,Goldberg Richard M.⁵,Meyers Jeffrey P.²,Pogue-Geile Kay L.⁶,Yothers Greg⁷,Sargent Daniel J.²,Alberts Steven R.⁸

Affiliation:

1. Department of Medicine, Mayo Clinic, Rochester, Minnesota2Department of Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota

2. Alliance for Clinical Trials in Oncology Statistics and Data Center, Mayo Clinic, Rochester, Minnesota

3. Division of Hematology and Oncology, University of Florida, Gainesville

4. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota

5. Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus

6. Pathology Laboratory, National Surgical Adjuvant Breast and Bowel Project/NRG Oncology, Pittsburgh, Pennsylvania

7. NRG Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania

8. Department of Oncology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The survival outcome differs between left-sided colon cancer and middle/low rectal cancer after colorectal hepatic metastasectomy;Journal of Gastrointestinal Surgery;2024-08

2. The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer;Discover Oncology;2024-06-25

3. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2024-06

4. Preclinical efficacy of carfilzomib in BRAF‐mutant colorectal cancer models;Molecular Oncology;2024-02-13

5. Clinical and Molecular Landscape of Mismatch Repair Deficient (Dmmr) Colon Cancer (Cc) Patients: Data from a Large Consecutive Single-Center Cohort;2024